Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access type 2 diabetes specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-
Sponsor: Brigham and Women's Hospital
Check if you qualify for this type 2 diabetes clinical trial in New York, NY
If you're searching for type 2 diabetes treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.